• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of May 1, 2013

  • Print
  • Share
  • E-mail

Product Detail

Product Description Source Plasma
Recall Number B-1307-13
Classification Class II
Code Info LR0215098, LR0222997, LR0224240, LR0224594, LR0225469, LR0225667, LR0230265, LR0234059, LR0234404, LR0234950, LR0235270, LR0235967, LR0236282, LR0236833, LR0237158, LR0237695, LR0237950, LR0239090, LR0239505, LR0240004, LR0240475, LR0241134, LR0241575, LR0242181, LR0242431, LR0243068, LR0243485, LR0244000, LR0252971, LR0253257, LR0253927, LR0254208, LR0254915, LR0255241, LR0256141, LR0256299, LR0256898, LR0257253, LR0257828, LR0258242, LR0258846, LR0259231, LR0259832, LR0260202, LR0260728, LR0261231, LR0261687, LR0262202, LR0262634, LR0263137, LR0263649, LR0264189, LR0264762, LR0265230, LR0265636, LR0266344, LR0266621, LR0271856, LR0274376, LR0274651
Product Distributed Qty 60 units
Reason For Recall Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.

Event Detail

Event Id 48241
Product Type Biologics
Status Terminated
Recalling Firm DCI Biologicals Little Rock LLC
City Little Rock
State AR
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2008-03-24
Initial Firm Notification of Consignee or Public FAX
Distribution Pattern United Kingdom